Molecular markers of B-cell lymphoma

Seminars in Cancer Biology

Volumn 9, Issue 2, 1999, Pages 139-147

  Stevenson, George T ^a   Cragg, Mark S ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibody; Leukemia; Lymphocyte; Lymphoma; Myeloma

Indexed keywords

CD20 ANTIGEN; CD22 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CELL SURFACE IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CELL SURFACE; HUMAN; LYMPHOCYTE; MAMMAL CELL; MOLECULAR BIOLOGY; REVIEW; TUMOR CLASSIFICATION;

EID: 0033034935     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0085     Document Type: Article

References (35)

1. Hjalgrim H, Frisch M, Begtrup K, Melbye M. Recent increase in incidence of non-Hodgkin's lymphoma among young men and women in Denmark. Br J Cancer. 73:1996;951-954.
2. Jaffe ES. Follicular lymphomas: possibility that they are benign tumors of the lymphoid system. J Natl Cancer Inst. 70:1983;401-403.
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML. A revised European-American Classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 84:1994;1361-1392.
4. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. The Leucocyte Antigen Facts Book. 1997;Academic Press, San Diego. p. 1-611.
5. Aisenberg CA. Utility of gene rearrangements in lymphoid malignancies. Ann Rev Med. 44:1993;75-84.
6. Stevenson F, Sahota S, Zhu D, Ottensmeier C, Chapman C, Oscier D, Hamblin T. Insight into the origin and clonal history of B cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev. 162:1998;247-259.
7. Stewart AK, Schwartz RS. Immunoglobulin V regions and the B cell. Blood. 83:1994;1717-1730.
8. Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol. 40:1992;259-263.
9. Anderson KC. Boyd AW, Fisher CD, Leslie D, Schlossman SF, Nadler LM. Hairy cell leukemia: a tumor of pre-plasma cells. Blood. 65:1985;620-629.
10. Miller ML, Fishleder AJ, Tubbs RR. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Am J Clin Pathol. 96:1991;100-108.
11. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol. 25:1994;1020-1029.
12. Rodriguez J, Pugh WC, Cabanillas F. T cell-rich B cell lymphoma. Blood. 82:1993;1586-1589.
13. Raffeld M, Neckers L, Longo DL, Cossman J. Spontaneous alteration of idiotype in a monoclonal B cell lymphoma. N Engl J Med. 312:1985;1653-1658.
14. Rickinson AR, Moss W. Human cytotoxic T lymphocyte responses to Epstein Barr virus infection. Ann Rev Immunol. 15:1997;405-431.
15. Kyle RA. Monoclonal gammopathy of undetermined significance. Blood Rev. 3:1994;135-141.
16. Burrows PD, Cooper MD. B cell development and differentiation. Curr Opin Immunol. 9:1997;239-244.
17. Stevenson GT, Jones DB. Lymphoma. Bradley J, McCluskey J. Clinical Immunology. 1997;507-520 Oxford University Press Inc, New York.
18. Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood. 65:1985;1349-1363.
19. Meeker T, Lowder J, Cleary ML, Stewart S, Warnke R, Sklar J, Levy R. Emergence of idiotype variants during treatment of B cell lymphoma with anti-idiotype antibodies. N Engl J Med. 312:1985;1658-1665.
20. Kanavaros P, Gaulard P, Charlotte F, Martin N, Ducos C, Lebezu M, Mason DY. Discordant expression of immunoglobulin and its associated molecule Mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol. 146:1995;735-741.
21. Thompson AA, Talley JA, Do HN, Kagan L, Kunkel L, Berenson J, Cooper MD, Saxon A, Wall R. Aberrations of the B cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood. 90:1997;1387-1394.
22. Lynch RG, Graff RJ, Sirisinha S, Simms ES, Eisen HN. Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci USA. 69:1972;1450-1544.
23. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R. Vaccination of patients with B cell lymphoma using autologous antigen pulsed dendritic cells. Nature Med. 2:1996;52-58.
24. Tedder TF, Engel P. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today. 15:1994;450-454.
25. Press OW, Appelbaum F, Ledbetter JA, Martin PJ, Zarling J, Kidd P, Thomas ED. Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphoma. Blood. 69:1987;584-591.
26. Shan D, Ledbetter JA, Press OW. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood. 91:1998;1644-1652.
27. Maloney DG, Grillolopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood. 90:1997;2188-2195.
28. Corcoran MC, Eary J, Bernstein I, Press OW. Radioimmunotherapy strategies for non-Hodgkin's lymphomas. Ann Oncol. 8:1997;1-33.
29. O'Rourke L, Tooze R, Fearon DT. Co-receptors of B-lymphocytes. Curr Opin Immunol. 9:1997;324-329.
30. Powell LD, Varki A. I-type lectins. J Biol Chem. 270:1995;14243-14246.
31. Shan D, Press OW. Constitutive endocytosis and degradation of CD22 by human B cells. J Immunol. 154:1995;4466-4475.
32. Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V, Ramilo O, Thorpe PE, Uhr JW, Vitetta ES. A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B cell lymphomas resistant to conventional therapy. Blood. 82:1993;2624-2633.
33. French RR, Hamblin U, Bell AJ, Tutt AL, Glennie MJ. Treatment of B cell lymphomas with combination of bispecific antibodies and saporin. Lancet. 346:1995;223-224.
34. Lurid F, Solvason N, Grimaldi JC, Parkhouse RME, Howard M. Murine CD38 - an immunoregulatory ectoenzyme. Immunol Today. 69:1995;469-473.
35. van Kooten C, Banchereau J. Function of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol. 9:1997;330-337.